Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

Bryan Williams · SciRah

Researcher profile · Semantic Scholar

Bryan Williams

Share profile

Bryan Williams — researcher profile on SciRah

h-index: 10
Works: 34
Citations: 2,460

Most-cited papers

Artificial intelligence in healthcare: transforming the practice of medicine
Junaid Bajwa, Usman Munir, A. Nori, Bryan Williams
2021Future healthcare journal1,497 citations Open access
Semantic Scholar
Neutralising antibody activity against SARS-CoV-2 VOCs B.1.617.2 and B.1.351 by BNT162b2 vaccination
Emma C. Wall, Mary Y. Wu, R. Harvey, G. Kelly +21 more
2021The Lancet489 citations Open access
Semantic Scholar
Ability of AZD1222 vaccination to elicit neutralising antibodies against SARS-CoV-2 VOC B.1.617.2 (Delta)
Emma C. Wall, Mary Y. Wu, R. Harvey, Gavin Kelly +20 more
2021The Lancet115 citations Open access
Semantic Scholar
Three-dose vaccination elicits neutralising antibodies against SARS-CoV-2 Omicron variant
Mary Y. Wu, Emma C. Wall, E. Carr, R. Harvey +22 more
2022The Lancet90 citations Open access
Semantic Scholar
Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt-Jakob disease: evaluation of a first-in-human treatment programme.
S. Mead, A. Khalili-Shirazi, C. Potter, T. Mok +17 more
2022Lancet Neurology78 citations Open access
Semantic Scholar
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
Mary Y. Wu, E. Carr, R. Harvey, Harriet V. Mears +15 more
2022The Lancet45 citations Open access
Semantic Scholar
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
E. Carr, Mary Y. Wu, J. Gahir, R. Harvey +31 more
2023Lancet. Infectious Diseases (Print)24 citations Open access
Semantic Scholar
Emergence of new subgenomic mRNAs in SARS-CoV-2
Harriet V. Mears, George R. Young, Theo Sanderson, R. Harvey +14 more
2022bioRxiv16 citations Open access
Semantic Scholar
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion
Harriet V. Mears, George R. Young, Theo Sanderson, Ruth Harvey +23 more
2025PLoS Biology15 citations Open access
Semantic Scholar
Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants
T. Russell, H. Townsley, S. Abbott, J. Hellewell +22 more
2024PLoS Biology13 citations Open access
Semantic Scholar
Divergent performance of vaccines in the UK autumn 2023 COVID booster campaign
Marianne J Shawe-Taylor, David Greenwood, Agnieszka Hobbs, G. Dowgier +16 more
2024The Lancet10 citations Open access
Semantic Scholar
Sotrovimab restores neutralization against current Omicron subvariants in patients with blood cancer
Mary Y. Wu, S. Shepherd, A. Fendler, E. Carr +62 more
2023Cancer Cell9 citations Open access
Semantic Scholar
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study.
T. Russell, H. Townsley, J. Hellewell, J. Gahir +40 more
2024Lancet. Infectious Diseases (Print)8 citations Open access
Semantic Scholar
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
H. Townsley, J. Gahir, T. Russell, David Greenwood +33 more
2024PLoS ONE8 citations Open access
Semantic Scholar
Independent SARS-CoV-2 staff testing protected academic and health-care institutions in northwest London
Chris Bailey, Theo Sanderson, H. Townsley, Jacki Goldman +49 more
2023The Lancet8 citations Open access
Semantic Scholar
Influence of IL-6 levels on patient survival in COVID-19
N. Arulkumaran, T. Snow, A. Kulkarni, D. Brealey +14 more
2021Journal of critical care7 citations Open access
Semantic Scholar
SARS-CoV-2 mucosal neutralising immunity after vaccination.
E. Carr, Guilia Dowgier, David Greenwood, L. Herman +34 more
2023Lancet. Infectious Diseases (Print)6 citations Open access
Semantic Scholar
Non-hospitalised, vaccinated adults with COVID-19 caused by Omicron BA.1 and BA.2 present with changing symptom profiles compared to those with Delta despite similar viral kinetics
H. Townsley, E. Carr, T. Russell, L. Adams +23 more
2022medRxiv6 citations Open access
Semantic Scholar
Investigation of Influenza A(H5N1) Virus Neutralization by Quadrivalent Seasonal Vaccines, United Kingdom, 2021–2024
P. Stevenson-Leggett, L. Adams, David Greenwood, Abi Lofts +10 more
2025Emerging Infectious Diseases5 citations Open access
Semantic Scholar
Within-host SARS-CoV-2 viral kinetics informed by complex life course exposures reveals different intrinsic properties of Omicron and Delta variants
T. Russell, H. Townsley, S. Abbott, J. Hellewell +22 more
2023medRxiv4 citations Open access
Semantic Scholar
Adults in Ghana generate higher and more durable neutralising antibody titres following primary course COVID-19 vaccination than matched UK adults: The HERITAGE Study
E. M. Kwesi-Maliepaard, Yakubu Alhassan, E. Quaye, Vera M. Kotey +67 more
2025BMC Medicine3 citations Open access
Semantic Scholar
Third exposure to COVID-19 infection or vaccination differentially impacts T cell responses
G. Ahimbisibwe, David Greenwood, Katalin Wilkinson, J. Gahir +33 more
2025Journal of Infection3 citations Open access
Semantic Scholar
Defining Potential Therapeutic Targets in Coronavirus Disease 2019: A Cross-Sectional Analysis of a Single-Center Cohort
N. Arulkumaran, T. Snow, A. Kulkarni, D. Brealey +13 more
2021Critical Care Explorations3 citations Open access
Semantic Scholar
Assessment of human immunity to A/H3N2 influenza subclade K during 2025 emergence
Ruth Harvey, Ceilidh Welsh, A. M. Byrne, David Greenwood +43 more
2026EBioMedicine2 citations Open access
Semantic Scholar
Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults
E. Carr, H. Townsley, Mary Y. Wu, K. Wilkinson +35 more
2023bioRxiv2 citations Open access
Semantic Scholar
34 COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history
H. Townsley, J. Gahir, T. Russell, E. Carr +32 more
2023Clinical Infection in Practice2 citations Open access
Semantic Scholar
Accurate evaluation of live-virus microneutralisation for SARS-CoV-2 variant JN.1 in the assessment of vaccination and therapeutics.
G. Dowgier, Agnieszka Hobbs, David Greenwood, Marianne J Shawe-Taylor +15 more
2025Vaccine1 citations Open access
Semantic Scholar
Immunogenicity of three-dose COVID-19 vaccines in people living with multiple sclerosis
Marianne J Shawe-Taylor, David Greenwood, A. He, Agnieszka Hobbs +28 more
2025BMJ Neurology Open1 citations
Semantic Scholar
24 B cell depletion therapy in people with Multiple Sclerosis impacts on antibody response to COVID-19 mRNA vaccines
Marianne J Shawe-Taylor, David Greenwood, A. He, Agnieszka Hobbs +22 more
2025Clinical Infection in Practice0 citations Open access
Semantic Scholar
15 Divergent performance of bivalent BA.5 and monovalent XBB.1.5 COVID-19 vaccines given as annual booster
Marianne J Shawe-Taylor, David Greenwood, Agnieszka Hobbs, G. Dowgier +17 more
2025Clinical Infection in Practice0 citations Open access
Semantic Scholar
Design and development of a SARS and MERS Combination Vaccine
Antonio Casal, M. D. Yousif, Samuel Ellis, Claire M. Smith +9 more
2025bioRxiv0 citations Open access
Semantic Scholar
Accurate evaluation of live-virus microneutralization for SARS-CoV-2 variant JN.1
G. Dowgier, Agnieszka Hobbs, David Greenwood, Marianne J Shawe-Taylor +15 more
2024bioRxiv0 citations Open access
Semantic Scholar
33 Fourth dose bivalent mRNA vaccines containing BA.1 significantly augment neutralising antibody titres against SARS-COV-2 Omicron sub-lineages XBB and BQ.1.1 in healthy adults
Mary Y. Wu, E. Carr, Ruth Harvey, J. Gahir +29 more
2023Clinical Infection in Practice0 citations Open access
Semantic Scholar
SARS-CoV-2 mucosal neutralising immunity is enhanced by vaccination and infection
E. Carr, Guilia Dowgier, David Greenwood, L. Herman +34 more
0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

E. Carr×25
Invite
E. Carr — researcher profile on SciRah
G. Kassiotis×22
Invite
G. Kassiotis — researcher profile on SciRah
C. Swanton×21
Invite
C. Swanton — researcher profile on SciRah
Vincenzo Libri×20
Invite
Vincenzo Libri — researcher profile on SciRah

×19

Invite

R. Beale — researcher profile on SciRah

Emma C. Wall×19

Invite

Emma C. Wall — researcher profile on SciRah

Invite

S. Gandhi — researcher profile on SciRah

Invite

S. Gamblin — researcher profile on SciRah

David L. V. Bauer×17

Invite

David L. V. Bauer — researcher profile on SciRah

Ruth Harvey×17

Invite

Ruth Harvey — researcher profile on SciRah

Invite

L. Adams — researcher profile on SciRah

Agnieszka Hobbs×16

Invite

Agnieszka Hobbs — researcher profile on SciRah